Sex differences in the relationship between depression and Alzheimer's disease-mechanisms, genetics, and therapeutic opportunities
- PMID: 38903903
- PMCID: PMC11188317
- DOI: 10.3389/fnagi.2024.1301854
Sex differences in the relationship between depression and Alzheimer's disease-mechanisms, genetics, and therapeutic opportunities
Abstract
Depression and Alzheimer's disease (AD) are prevalent neuropsychiatric disorders with intriguing epidemiological overlaps. Their interrelation has recently garnered widespread attention. Empirical evidence indicates that depressive disorders significantly contribute to AD risk, and approximately a quarter of AD patients have comorbid major depressive disorder, which underscores the bidirectional link between AD and depression. A growing body of evidence substantiates pervasive sex differences in both AD and depression: both conditions exhibit a higher incidence among women than among men. However, the available literature on this topic is somewhat fragmented, with no comprehensive review that delineates sex disparities in the depression-AD correlation. In this review, we bridge these gaps by summarizing recent progress in understanding sex-based differences in mechanisms, genetics, and therapeutic prospects for depression and AD. Additionally, we outline key challenges in the field, holding potential for improving treatment precision and efficacy tailored to male and female patients' distinct needs.
Keywords: Alzheimer’s disease; depression; genetics; mechanisms; sex differences; therapeutic opportunities.
Copyright © 2024 Chen, Wang, Liu, Xu and Mao.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Depression in Alzheimer's Disease: Epidemiology, Mechanisms, and Treatment.Biol Psychiatry. 2024 Jun 1;95(11):992-1005. doi: 10.1016/j.biopsych.2023.10.008. Epub 2023 Oct 20. Biol Psychiatry. 2024. PMID: 37866486 Review.
-
Network Structure of Depressive Symptomatology in Elderly with Cognitive Impairment.Medicina (Kaunas). 2024 Apr 23;60(5):687. doi: 10.3390/medicina60050687. Medicina (Kaunas). 2024. PMID: 38792870 Free PMC article.
-
Microglial dysfunction connects depression and Alzheimer's disease.Brain Behav Immun. 2016 Jul;55:151-165. doi: 10.1016/j.bbi.2015.11.011. Epub 2015 Nov 27. Brain Behav Immun. 2016. PMID: 26612494 Review.
-
Sex-Driven Differences in the Effectiveness of Individualized Clinical Management of Alzheimer's Disease Risk.J Prev Alzheimers Dis. 2022;9(4):731-742. doi: 10.14283/jpad.2022.44. J Prev Alzheimers Dis. 2022. PMID: 36281678
-
The role of sex differences in depression in pathologically defined Alzheimer's disease.Front Aging Neurosci. 2023 May 10;15:1156764. doi: 10.3389/fnagi.2023.1156764. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37234269 Free PMC article.
Cited by
-
Sex-specific association of depressive symptom trajectories with cognitive decline and clinical progression in mild cognitive impairment.Alzheimers Dement. 2025 Aug;21(8):e70548. doi: 10.1002/alz.70548. Alzheimers Dement. 2025. PMID: 40754890 Free PMC article.
References
-
- Achtyes E., Keaton S. A., Smart L. A., Burmeister A. R., Heilman P. L., Krzyzanowski S., et al. . (2020). Inflammation and kynurenine pathway dysregulation in post-partum women with severe and suicidal depression. Brain Behav. Immun. 83, 239–247. doi: 10.1016/j.bbi.2019.10.017, PMID: - DOI - PMC - PubMed
-
- Akinci M., Peña-Gómez C., Operto G., Fuentes-Julian S., Deulofeu C., Sánchez-Benavides G., et al. . (2022). Prepandemic Alzheimer disease biomarkers and anxious-depressive symptoms during the COVID-19 confinement in cognitively unimpaired adults. Neurology 99, e1486–e1498. doi: 10.1212/WNL.0000000000200948, PMID: - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources